Stay updated on CY, Pembrolizumab, GVAX & SBRT in Locally Adv Pancreatic Ca Clinical Trial
Sign up to get notified when there's something new on the CY, Pembrolizumab, GVAX & SBRT in Locally Adv Pancreatic Ca Clinical Trial page.

Latest updates to the CY, Pembrolizumab, GVAX & SBRT in Locally Adv Pancreatic Ca Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision: v3.3.2 replaces v3.2.0; no study content or critical UI changes were observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check20 days agoChange DetectedAn administrative government funding/operating status notice was removed. The study details, eligibility criteria, and contact information remain available on the page.SummaryDifference0.4%

- Check34 days agoChange DetectedNo significant additions or deletions detected for this page.SummaryDifference0.5%

- Check63 days agoChange DetectedUpdated operating status notice and version to v3.2.0, replacing v3.1.0.SummaryDifference4%

- Check70 days agoChange DetectedUpgrade version from v3.0.2 to v3.1.0; no other content changes are specified.SummaryDifference0.1%

- Check84 days agoChange DetectedUpdated page revision from v3.0.1 to v3.0.2; removed the Back to Top link.SummaryDifference0.3%

Stay in the know with updates to CY, Pembrolizumab, GVAX & SBRT in Locally Adv Pancreatic Ca Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CY, Pembrolizumab, GVAX & SBRT in Locally Adv Pancreatic Ca Clinical Trial page.